US 9,744,234 · Application 13/877,585 · Granted Aug 29, 2017
US 9,744,234
Methods of treating ankylosing spondylitis using il-17 antagonists
Estimated expiration
May 5, 2033
6y 183d remaining
- Could not fetch continuity data for application PCTEP2011069476: Resource not found (404)
Earliest effective filing
Nov 4, 2011
+ 20 years
Nov 4, 2031
PTA +548d
May 5, 2033
No TD
—
Final
May 5, 2033
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- April 3, 2013
- Earliest effective filing
- November 4, 2011
- Issue date
- August 29, 2017
- PTA
- +548 days
- Base expiry (before PTA)
- November 4, 2031
November 4, 2011 + 20 years = November 4, 2031 + 548 PTA days = May 5, 2033
- National stage entry of application PCTEP2011069476, filed Nov 4, 2011
- PRO61/410,533 — Provisional — not used for base term
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 13/877,585 · US 9,744,234
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 9,744,234: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US9744234Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.